Abstract | dc.description.abstract | Background. In Chile, the novel influenza A (H1N1) epidemic began in the middle-high income area of
Santiago. Clinical and laboratory surveillance was intensified with the aim to characterize the epidemic and
determine its impact in a large hospital setting.
Methods. Demographic and clinical data were obtained from all patients whose symptoms met the clinical
definition of influenza A (H1N1) infection during the epidemic period. Laboratory confirmation was obtained by
use of a nasopharyngeal antigen detection test for influenza A and/or influenza A (H1N1) polymerase chain
reaction (PCR). A case was considered confirmed if the antigen detection test result for influenza A and/or the
PCR test result were positive.
Results. The total number of emergency department (ED) visits increased by 88.5% from a mean of 14,489
ED visits in 2006–2008 to a mean of 27,308 ED visits in 2009, during the epidemic period. There were 10,048
patients who were clinically diagnosed with influenza A (H1N1), and they represented 78% of all visits, of which
4591 (45.6%) were laboratory confirmed. The median time from symptom onset to diagnosis was 1 day, and
99.7% of individuals received antiviral treatment. School-aged children represented 67% of ED visits at the beginning
of the epidemic and 24% of ED visits at the end of the epidemic. Only 2% of cases were hospitalized; of these,
70% of cases occurred in patients 6–50 years of age, and 32% of cases occurred in patients who had an underlying
medical condition. Eleven patients (age range, 1–53 years) required admission to the intensive care unit (ICU); 6
of these patients had pneumonia with or without hemodynamic shock. No influenza-associated deaths occurred.
Conclusions. Many cases of influenza A (H1N1) occurred in school-aged and adult individuals who required
an ED visit; these visits resulted in a low impact on the use of hospital beds. Aggressive ICU management and/
or experience in extracorporeal membrane oxygenation significantly improved outcomes. Early antiviral treatment
may have played an important role in the low number of severe cases. Vaccines targeted for school-aged children
and young adults may modify the first epidemic wave in the northern hemisphere. | en_US |